NCT01164241
- Conditions
- Amyloidosis, Primary Cutaneous, Anaphylaxis, Dermatitis, +15 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.
NCT01164241
NCT07787507
NCT07264335
NCT06702462
NCT01197053
NCT05922891
NCT07778537
NCT06116565
NCT07772388
NCT01716494